Automated insulin delivery (AID) systems reduce diabetes distress and fear of hypoglycemia, improve quality of life, and increase awareness about hypoglycemia in adults, children, and adolescents ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...

This growth will be mostly driven by insulin delivery devices ... MiniMed 600 series and 700 series pump systems. "Luna Diabetes trials automated wearable insulin pump" was originally created ...

It is also the first application to enable insulin delivery from a compatible Apple ... as a predicate device for future interoperable Automated Insulin Dosing (AID) submissions - providing ...

Insulet (Nasdaq:PODD) shares ticked up today on third-quarter results that came in well ahead of the consensus forecast.

SAN DIEGO, CA / ACCESSWIRE / October 23, 2024 / Luna Diabetes announces the start of its pivotal trial for the Luna System today. Luna is the first automated insulin delivery solution intended for ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Insulet ( (PODD) ) has released its Q3 earnings. Here is a breakdown of the information Insulet presented to its investors. Insulet ...

Analysis - Pharmac's decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New ...